Final Invention Statement & Certification

The Final Invention Statement and Certification, filed on HHS Form 568, is a required grant-closeout document for NIH and other Public Health Service (PHS) federal awards. It is the mechanism by which a recipient institution formally certifies to the funding agency, at the end of a project period, either (a) a complete list of every Bayh-Dole ‘subject invention’ conceived or first actually reduced to practice under the award, or (b) that no subject invention was made. Copies of the form and current instructions are maintained by NIH at grants.nih.gov, and submission is made electronically through the Interagency Edison (iEdison) system, the shared disclosure and reporting platform used across federal funding agencies for Bayh-Dole invention reporting.

What it certifies

The standard patent rights clause implementing the Bayh-Dole Act, at 37 CFR 401.14, obligates a recipient to disclose each subject invention to the funding agency as inventions arise during the project — specifically, within two months of an inventor’s written disclosure to the recipient’s own patent-matters personnel (37 CFR 401.14(c)(1), (f)(2)). HHS Form 568 sits downstream of that ongoing obligation: it is the closeout-stage roll-up certification confirming that reporting has, in fact, been completed for the award as a whole, or affirmatively stating that there was nothing to report. A recipient with zero inventions still files the form — a ‘negative’ certification is not optional simply because no invention occurred.

Who files it

The form is signed by the recipient institution’s authorized organizational representative (typically the signing official in the sponsored-programs office), usually prepared in coordination with the institution’s technology transfer office, which holds the underlying invention-disclosure and iEdison records referenced on the form.

When it is due

HHS Form 568 is submitted as part of NIH’s closeout package alongside the final Research Performance Progress Report and the final Federal Financial Report (SF-425). NIH closeout guidance has, across different documents and points in time, referenced day counts in this range — generally 90 to 120 calendar days from the end of the project period or the point at which it becomes clear no competing renewal will be funded (a somewhat shorter or longer window can also apply when a grant is administratively transferred to a new institution). Because NIH has periodically revised its own closeout timelines, and because the government-wide default closeout deadline under 2 CFR 200.344 has itself changed in recent Uniform Guidance revisions, always confirm the exact current deadline against the specific Notice of Award and NIH’s current Grants Policy Statement rather than relying on a fixed figure. NIH has issued guide notices specifically reminding recipients to submit closeout reports — including the invention statement — in a timely and accurate fashion, underscoring that this is treated as a real compliance deadline, not a formality.

Consequences of noncompliance

Two distinct risks are worth separating. First, under the Bayh-Dole standard patent rights clause, a recipient that fails to properly disclose or report a subject invention can lose its rights to that invention — 37 CFR 401.14(d) allows the funding agency to obtain title to an invention the contractor failed to disclose or elect title to within the required timeframes. This is a title-forfeiture risk tied to the underlying disclosure obligation, not specifically to the HHS-568 filing itself. Second, an incomplete or late closeout package — including a missing Final Invention Statement — can delay the formal closeout of the award, complicate the institution’s standing on the specific grant, and, because closeout performance is a factor federal agencies can weigh in future award and risk determinations, create friction for the institution’s broader funding relationship with the agency. Neither consequence is automatic on any single missed date, but both are real, documented risks tied to treating this filing as routine paperwork rather than a compliance deliverable.

How it fits the closeout picture

HHS Form 568 is one piece of a larger closeout obligation. See CASRAI’s guide to the federal grant closeout process for how it fits alongside the final financial report, final progress report, and property disposition requirements under 2 CFR 200.344, and the iEdison invention reporting guide for how ongoing invention disclosure and utilization reporting work across the life of an award, not just at closeout. For the underlying statutory and regulatory framework this form implements, see CASRAI’s Bayh-Dole Act entry.